March 20, 2016
Please join us in congratulating Dr. Pengbo Zhou on receiving a one-year $500,000 grant from Highline Therapeutics.
Pengbo Zhou, PhDProfessor of Pathology and Laboratory Medicine
Dr. Zhou will work with Highline Therapeutics to develop chemical inhibitors of the CUL4 E3 ubiquitin ligase and test the ability of these compounds to treat cancers with increased CUL4 activity.
February 11, 2016
In modern-day gold rush of genetic testing, profit placed above proofGenetic testing could lead to huge scientific breakthroughs in preventing cancer, but it can also be misleading. In Part 1 of a CBS News investigation, we reported about the questionable marketing claims that a blood test can detect cancer before symptoms appear. In Part 2 of the investigation, we look into the booming genetic testing industry that some call the modern-day gold rush.Stephen Master, MD, PhDDirector, Central LaboratoryAn average of eight to 10 genetic testing products are being put on the market every day,...
January 27, 2016
Please join us for a live webcast of Dr. Mark Rubin's "Precision Medicine" presentation at Executive Grand Rounds on Wednesday, January 27 at 5:00pm EST.
January 26, 2016
Meyer Director Lewis Cantley, Ph.D., and Mark Rubin, M.D., Associate Director of Precision Medicine, have been named on Thomson Reuter's annual list of The World's Most Influential Scientific Minds. Mark A Rubin, MDDirector, Institute for Precision MedicineThe list was compiled by analyzing citation data over an 11-year period (2003-2013), and identifying those who published the greatest number of highly cited papers in that time frame. Highly cited papers rank in the top 1% of the citation distributions of comparable papers, matched for field and age.
January 23, 2016
A protein that normally exists in the mitochondria of healthy cells appears to travel to the nucleus of cancer cells and promote metastasis, according to new research from Weill Cornell Medicine investigators.The protein, Bcl-xL, exists in the mitochondria of cells. It has long been known that Bcl-xL's primary function is to prevent cell death, known as apoptosis. Cancer cells have an even higher amount of Bcl-xL than healthy cells, so scientists thought that the protein was helping cancer cells to survive. But in their study, published Jan. 20 in Nature Communications, investigators...
January 20, 2016
In his State of the Union address President Barack Obama made finding a cure for cancer a moonshot of his final year in office. It's a lofty goal as cancer is not just one disease but many. But with the help of doctors at a New York institute one woman may have found her cure, tailored just for her. NY1's Erin Billups filed the following report.Irene Price was diagnosed with bladder cancer in 2008. She was treated, it went away but then it came back in 2013. She had surgery to remove her bladder and underwent chemotherapy. A short time later it reappeared in her liver."I responded to...
November 30, 2015
Congratulations to Dr. Ethel Cesarman on receiving a two-year $996,000 Starr Cancer Consortium grant!
Along with her collaborators Dr. Ari Melnick at WCMC and Drs. Robert Roeder and David Allis at Rockefeller University, Dr. Cesarman will be studying the role of linker histone H1 mutations in lymphoma pathogenesis.
Ethel Cesarman, MD, PhDProfessor of Pathology and Laboratory Medicine
November 13, 2015
Precision Medicine team at Weill Cornell Medicine and NewYork-Presbyterian will introduce whole exome sequencing test, EXaCT-1, to clinical setting
October 21, 2015
The department is pleased to announce the appointment of Brian Robinson, MD to Chief of Surgical Pathology. In this role, Dr. Robinson will be responsible for day-to-day operations of Surgical Pathology and will report directly to Dr. Alain Borczuk.
Brian Robinson, MDChief, Surgical Pathology
After graduating from Weill Cornell Medical College, Brian joined our residency training program in anatomic pathology. After completing our program in stellar fashion, he completed a fellowship in urologic pathology at the Johns Hopkins Hospital. We recruited Brian back to our department in July 2010.